药品名称FURADANTIN
申请号009175产品号001
活性成分NITROFURANTOIN市场状态处方药
剂型或给药途径SUSPENSION;ORAL规格25MG/5ML
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构CASPER PHARMA LLC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
009175039APLetter2010/10/19下载
009175038APLetter2010/11/02下载
009175038APLabel2016/03/18下载
009175037APLabel2009/02/10下载
009175037APLetter2009/02/13下载
009175036APLabel2013/11/04下载
009175036APLetter2013/11/07下载
009175033APLetter2008/06/03下载
009175019APReview2006/05/10下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
009175044AP2016/07/11Manufacturing Change or Addition
009175043AP2014/11/03Manufacturing Change or Addition
009175039AP2010/10/14Labeling Revision
009175038AP2010/10/27Labeling Revision
009175037AP2009/02/06Labeling Revision
009175036AP2013/11/04Labeling Revision
009175033AP2008/05/30Labeling Revision
009175026AP1999/08/25Labeling Revision
009175025AP1998/12/03Package Change
009175024AP1996/10/15Expiration Date Change
009175023AP1997/03/27Labeling Revision
009175022AP1998/04/07Labeling Revision
009175021AP1993/08/09Control Supplement
009175020AP1999/02/11Labeling Revision
009175019AP1988/05/13Labeling Revision
009175016AP1987/06/12Labeling Revision
009175015AP1993/05/18New or Modified Indication
009175013AP1982/11/18Labeling Revision
009175012AP1987/06/12Labeling Revision
009175011AP1979/12/17Labeling Revision
009175008AP1978/01/03Manufacturing Change or Addition
009175006AP1973/11/23Supplement
009175000AP1953/12/23Approval